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Objectives: Normothermic cardiopulmonary b pass has been proposed as a 
more physiologic technique than hypothermic bypass for the maintenance 
of the body during cardiac surgery. The aims of this study were to 
investigate the effects of systemic perfusion temperature on clinical out- 
come after coronary revascularization. Methods: Three hundred patients 
(mean age 60 - 9 years, 88% male) were prospectively randomized into 
three groups: hypothermia (28 ° C, n = 100), moderate hypothermia (32 ° C, 
n = 100), and normothermia (37 ° C, n = 100). All patients received cold 
antegrade St. Thomas' Hospital crystalloid cardioplegic solution, and 
patients in the normothermic group were actively rewarmed uring cardio- 
pulmonary bypass (nasopharyngeal temperature 37 ° C). Results: No differ- 
ences were found between groups with respect to mortality (1%), intraaortic 
balloon pump use, perioperative infarction rates, focal neurologic deficits 
(1%), intubation time, intensive care unit stay, and postoperative hospital 
stay. Further stepwise regression analysis identified age and intensive care 
unit stay as important predictors of the variability in postoperative stay 
(both R 2 =0.114; p < 0.001), whereas perfusion temperature mained a
nonsignificant explanator. Normothermic perfusion necessitated larger 
doses of phenylephrine to maintain arterial pressure above 50 mm Hg 
during cardiopulmonary b pass (p < 0.0001 vs 28 ° C,p < 0.01 vs 32 ° C) but 
less requirement for electrical defibrillation during reperfusion (p < 0.05 vs 
32 ° C, p < 0.01 vs 28 ° C). Total chest drainage was not different between 
groups, but patients undergoing normothermic cardiopulmonary bypass 
required less transfusion of blood (p < 0.05 vs 28°C and 32 ° C) and 
platelets (p < 0.04 vs 32 ° C,p < 0.001 vs 28 ° C) in the postoperative p riod. 
Conclusions: Cardiopulmonary b pass temperature did not influence early 
clinical outcome after routine coronary artery bypass operations. Normo- 
thermic systemic perfusion was associated with an increased requirement 
for vasoconstrictors and reduced requirements for electrical defibrillation 
and transfusion of blood products. (J Thorac Cardiovasc Surg 1997;114: 
475-81) 
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S Ystemic hypothermia during cardiopulmonary bypass (CPB) has been regarded as an essential 
component of cardiac surgery since its inception. 
The rationale for this has been to offer some degree 
of cerebral protection and to provide a safety mar- 
gin in the event of technical difficulties with the CPB 
circuit. More recently, it has been suggested that 
some of the deleterious effects of CPB may be 
initiated or exaggerated by hypothermia. The use of 
normothermic techniques has been reported to con- 
fer several advantages over conventional hypother- 
mia, such as reduced bleeding, shorter intubation 
times, and improved hemodynamic parameters after 
the operation. 1-3 Current evidence is flawed, how- 
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ever, by inconsistencies in cardioplegic techniques 
and inadequate definitions of normothermic sys- 
temic perfusion, so that the independent effects of 
warm blood cardioplegia and normothermic CPB 
remain uncertain. The aims of this prospective 
randomized study were to investigate the effects of 
hypothermic, moderately hypothermic, and  actively 
normothermic CPB on clinical outcome after coro- 
nary artery bypass operations. 
Patients and methods 
Patient selection. Three hundred patients (265 men, 
mean age 60 2 9 years) undergoing primary isolated 
coronary revascularization u der the care of the academic 
unit were prospectively randomized by means of card 
allocation into one of three temperature groups (28 ° C, 
32 ° C, and 37 ° C). Prospective xclusion was limited to 
those with a previous history of stroke or transient isch- 
emic episodes. The study was approved by the United 
Bristol Healthcare Trust, and informed consent was ob- 
tained from all patients. 
Anesthetic techniques. Anesthetic techniques were 
standardized for all patients. Thiopental (1 to 3 mg/kg) 
was used for induction, fentanyl (3 to 5/xg/kg) and volatile 
agents delivered in a 50% air-oxygen mixture for mainte- 
nance, and propofol (3 mg/kg per hour) was infused 
during CPB. Neuromuscular blockade was achieved by 
pancuronium bromide (0.1 to 0.15 mg/kg), and ventilation 
was adjusted to maintain normocapnia. Alpha-stat acid- 
base management was adopted. 
CPB and surgical technique. Initial heparinization was 
accomplished with a dose of 3 mg/kg body weight and was 
supplemented asneeded to maintain an activated clotting 
time of 480 seconds. Preparation for CPB consisted of 
ascending aortic cannulation and two-stage venous can- 
nulation by way of the right atrial appendage. A standard 
CPB circuit was used in all patients, including polyvinyl- 
chloride tubing (Sorin Biomedica UK Ltd., Midhurst, 
United Kingdom), a Cobe roller pump (Cobe Laborato- 
ries, Inc., Lakewood, Colo.), hollow-fiber membrane oxy- 
genator (Monolyth, Sorin Biomedica Cardio, Saluggia, 
Italy), and a 40/xm arterial ine filter (Sorin Linea ABF 
40). The extracorporeal circuit was primed with 1000 ml 
Hartmann's solution, 500 ml succinylated gelatin plasma 
substitute (Gelofusine, B Braun Medical Ltd., Emmen- 
brficke, Switzerland), 60 mg heparin, and 0.5 gm/kg 
mannitol. Hypothermic and moderately hypothermic CPB 
were conducted with the perfusate at the appropriate 
temperature to reach a nasopharyngeal temperature of 
28 ° C or 32 ° C, respectively. Patients in the normothermic 
group were actively warmed to maintain anasopharyngeal 
temperature of 37°C throughout he period of CPB. 
Nonpulsatile perfusion was used throughout the proce- 
dure, and flow was maintained at a rate of 2.4 L/m 2 per 
minute for the normothermic group. This rate was re- 
duced to 2.0 and 1.8 L/m 2 per minute in the moderately 
hypothermic and hypothermic groups, respectively, when 
the lowest nasopharyngeal temperatures were reached. 
Phenylephrine was used as necessary to maintain systemic 
perfusion pressures at 50 to 60 mm Hg. Myocardial 
protection was achieved by the induction of electrome- 
chanical arrest with cold antegrade crystalloid cardiople- 
gia using St. Thomas' Hospital I solution and topical 
cooling using normal saline solution at 4 ° C. One liter of 
cardioplegic solution was administered initially, followed 
by 300 ml every 30 minutes during crossclamping or 
earlier whenever electrical activity was seen. Distal anas- 
tomoses were completed uring a single period of aortic 
crossclamping. Proximal anastomoses were completed on 
the beating heart with the use of an aortic partial occlu- 
sion clamp. Rewarming in the hypothermic and moder- 
ately hypothermic groups was commenced atthe comple- 
tion of all distal anastomoses. All patients were rewarmed 
with a temperature difference of 8 o C at the level of the 
heat exchanger between the blood and the rewarming 
fluid, and CPB was discontinued only after the patient was 
fully rewarmed to 37 ° C. Protamine sulfate was adminis- 
tered to reverse the effects of heparin at a 1:1 ratio. 
Autologous blood predonated after anesthetic induction 
was used for volume replacement, and blood remaining in 
the circuitwas reinfused to the patient via a 40/xm filter 
(SQ40S, Pall Europe Ltd., Portsmouth, United Kingdom). 
Postoperative management. At the end of the opera- 
tion, patients were transferred to the cardiac intensive 
care unit (ICU), where they were allowed to wake up 
when hemodynamically stable and blood loss from the 
chest drains was less than 100 ml/hr. When adequately 
rewarmed and oxygenated (an arterial oxygen tension, on 
an inspired oxygen fraction of 60%, greater than 80 mm 
Hg), patients were extubated. Postoperative homologous 
blood transfusion was administered if the hematocrit 
value fell below 25% and the patient's cardiovascular 
status demanded circulatory volume replacement. If the 
hematocrit value was higher, then synthetic olloid or 
plasma protein fraction was used for intravascular expan- 
sion. Excessive postoperative bleeding (greater than 200 
ml/hr) was treated initially by the administration of pro- 
tamine sulfate (25 to 50 mg) if free circulating heparin was 
demonstrated on a heparin-neutralizing thrombin time 
test. If bleeding continued and the platelet count was less 
than 100 × 109/L, a therapeutic dose of platelets was 
transfused rapidly. Because this transfusion contains a 
sufficient dose of fresh plasma, the administration of fresh 
frozen plasma was indicated only if the activated partial 
thromboplastin ratio and international normalized ratio 
remained greater than 1.5 after platelet ransfusion and if 
bleeding persisted. Reexploration for bleeding was under- 
taken if blood loss continued at a rate of more than 200 
ml/hr for 3 hours despite the aforementioned therapeutic 
measures or if blood loss was rapid and could not be 
replaced without compromising the hemodynamic state of 
the patient. Chest drains were removed when blood loss 
fell below 30 ml/hr for 2 consecutive hours. Drainage was 
recorded as total and 12-hour loss. The degree of inotro- 
pic support was defined as minimal (dopamine above 3 
/xg/kg per minute or dobutamine up to a dose of 5/zg/kg 
per minute), moderate (dopamine -> 5 tzg/kg per minute 
or dobutamine at 5 to 15 pg/kg per minute), and maxi- 
mum (the use of epinephrine, the combination of three or 
more different inotropic agents, and/or the use of an 
intraaortic balloon pump). The selective use of thermodi- 
lution catheters to evaluate hemodynamic parameters was 
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undertaken at the discretion of the clinicians involved in 
the management of the patient. Perioperative infarction 
was diagnosed by examination of serial 12-lead electro- 
cardiograms recorded before the operation and up to 5 
days after the operation. Evidence of infarction was 
diagnosed by the presence of new Q waves of 0.04 mm or 
more or by a reduction in the R wave of 25% or more in 
two or more leads. 
Statistical analysis. Data are presented as mean +- 
standard deviation unless stated otherwise. Unpaired 
comparisons of continuous variables were undertaken 
with the use of the Mann-Whitney U test and nominal 
variables were compared with the use of X a analysis. 
Stepwise multiple regression analyses were performed on 
the length of postoperative hospital stay to maximize the 
chance of detecting any influence of CPB temperature by
allowing for the effects of confounding variables. Vari- 
ables offered included age, sex, urgency of the operation 
(need for surgery within the same hospital admission), 
number of grafts performed, CPB time, aortic crossclamp 
time, surgeon grade (consultant or trainee), intubation 
time, ICU stay, and position on operating room list. 
Temperature was offered as binary dummy variables, one 
to indicate any difference between the hypothermic and 
moderately hypothermic groups and the other to indicate 
any difference between the moderately hypothermic and 
normothermic groups. 
Results 
Demographic data. Groups were matched with 
regard to major preoperative demographic and op- 
erative variables (Table I). Preoperative angio- 
graphic data demonstrated left ventricular ejection 
fraction less than 0.5 in 22% of patients. Eleven 
percent of patients were older than 70 years of age. 
The majority of patients had mild to moderate 
angina and were at relatively low risk according to 
the Parsonnet classification. 4 
Operative data. No significant differences were 
observed between groups with regard to number of 
grafts, doses of cardioplegic solution, and CPB and 
aortic crossclamp times (Table II). A single internal 
thoracic artery was used in 89% of patients and 
more than one arterial conduit was used in 10%. 
The doses of vasoconstrictor required to maintain a 
perfusion pressure above 50 mm Hg during CPB 
were significantly higher during normothermic sys- 
temic perfusion (p < 0.01 vs 28°C and 32 ° C). 
Despite this, the systemic vascular resistance re- 
mained significantly lower (p < 0.001 vs 28 ° C). 
Electrical defibrillation to restore sinus rhythm after 
reperfusion was required less frequently after nor- 
mothermic than after hypothermic CPB (p < 0.001 
vs 28 ° C, p < 0.01 vs 32 ° C). 
Mortality and morbidity. Three patients died in 
the study (28 ° C, n = 2; 37 ° C, n = 1). The incidence 
Table I. Demographic variables 
CPB temperature 
28 ° C 32 ° C 37 ° C 
Age (yr) 59.8 -+ 8.8 60.2 +- 8.9 60.4 _+ 8.7 
Sex (M/F) 88/12 85/15 92/8 
BSA(m 2) 1.9_+0.2 1.9-0.1 2.0_+0.5 
Angina class 
I 6 11 10 
II 48 40 59 
III 38 38 21 
IV 8 11 10 
Hypertension 22 24 21 
Diabetes mellitus 5 7 4 
Peripheral vascular disease 3 3 5 
Parsonnet score 
0-5 81 80 85 
5-10 17 17 13 
>10 2 3 2 
Elective operation 85 83 93 
Urgent operation 15 17 7 
BSA, Body surface area. 
of perioperative infarction (6.7%) and intraaortic 
balloon pump use (4.3%) were not significantly 
different between groups (see Table II). Two pa- 
tients had a stroke, and neurologic signs were ap- 
parent on the first postoperative day (32°C and 
37 ° C). Both patients made a good recovery, with 
lessening of their neurologic disability at 6 weeks' 
follow-up. 
Use of inotropic drugs. Inotropic drugs were used 
more frequently after normothermic perfusion than 
after hypothermic perfusion (p < 0.05 vs 28°C and 
32 ° C; Fig. 1). However, the majority of patients re- 
ceived only minimal doses to maintain mean arterial 
pressure above 65 mm Hg, and 90% of them were 
given dopamine as the inotropic agent of choice at 
doses ranging between 3 and 5/xg/kg per minute. 
Blood loss and blood product use. Five patients 
required reexploration for excessive bleeding on the 
day of the operation, but this complication was not 
associated with perfusion temperature. For all pa- 
tients in the study, total chest ube drainage, loss per 
unit body surface area per unit time, and 12-hour 
blood loss were also not significantly different be- 
tween groups (see Table II). However blood and 
blood product ransfusion were used less frequently 
after normothermic CPB, and the association with 
perfusion temperature was clear (Fig. 2). A similar 
trend was seen when comparing the mean number 
of units of blood and blood products that were 
transfused (Fig. 3). 
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Table II. Operative and postoperative ariables 
28 ° C 
CPB temperature 
32°C 37 ° C 
Number of grafts 3.2 + 0.8 3.0 _+ 0.9 3.0 -+ 0.9 
ITA 94 85 90 
CPB time (min) 83 + 21 80 _+ 26 82 - 24 
Aortic crossclamp time (min) 39 -+ 13 36 _+ 14 38 _+ 13 
SVR (dyne. sec. cm -s) 923 -+ 197 814 _+ 156 768 _+ 142" 
Phenylephrine (mg) 3.7 -+ 3.6 3.1 _+ 2.6 5.2 _+ 4.8-~ 
Electrical defibrillation 77 36 20:~ 
Perioperative infarction 6 8 6 
Intraaortic balloon pump use 3 6 4 
Deaths 2 0 1 
Stroke 0 1 1 
Period of intubation (hr) 8.6 - 5.8 9.1 _+ 7.7 9.0 _+ 6.9 
ICU stay (hr) 22 -+ 9 23 _+ 14 22 _+ 10 
Postoperative stay (days) 7.0 -+ 1.3 7.7 _+ 2.0 7.7 _+ 2.3 
Total blood loss (L) 1.2 + 0.5 1.2 _+ 0.6 1.1 --_ 0.4 
Corrected loss (L/mZ/hr) 23.4 -+ 8.6 26.2 + 13.4 22.6 _+ 10 
Twelve-hour blood loss (L) 0.6 --- 0.2 0.6 _+ 0.3 0.5 _+ 0.2 
Reoperation (bleeding/LCOS) 2/1 1/1 2/1 
ITA, Internal thoracic artery; SVR, systemic vascular resistance; LCOS, low cardiac output state. 
*p < 0.001 versus 28 ° C. 
"~p < 0.001 versus 28 ° C and 32 ° C. 
Sp < 0.001 versus 28 ° C,p < 0.01 versus 32 ° C. 
Intensive care and postoperative hospital stay. 
Systemic perfusion temperature did not influence 
the period of postoperative intubation or the total 
length of ICU and postoperative inpatient stay (see 
Table II). Stepwise regression identified age and 
ICU stay as significant explanators of postoperative 
hospital stay (both R 2 = 0.114; p < 0.0001). How- 
ever, systemic perfusion temperature r mained a
nonsignificant explanator. The relationship between 
postoperative hospital stay, age, and ICU stay can 
be expressed mathematically as follows: 
Postoperative stay (days) = 3.794 + 0.04 
(Age [years]) + 0.04 (ICU stay [hours]) 
Discussion 
The results of this randomized investigation sug- 
gest that the systemic perfusion temperatures stud- 
ied did not influence mortality, perioperative myo- 
cardial infarction, stroke, and intraaortic balloon 
pump use after coronary artery operations. One 
explanation for these results may be that the pa- 
tients studied were at relatively low risk, so that 
effects of any changes in systemic perfusion temper- 
ature were of less importance. In addition, it is 
possible that the multifactorial influences of clinical 
outcome after coronary artery operations out- 
weighed any small effect of systemic perfusion tern- 
perature on mortality and morbidity; because the 
frequency of such events was low, a much larger 
study would have been required to demonstrate 
differences in these end points. The study size was 
therefore calculated on the chance of detecting a
14% change in our current estimate of postoperative 
hospital stay. Postoperative hospital stay in our 
institution was estimated to be 7.3 _+ 1.6 days 
(mean _+ standard deviation). Assuming that a 
clinically meaningful reduction would be 1 day 
(14%), a sample size of 100 patients in each group 
would have been required to allow a 90% chance of 
detecting an effect of perfusion temperature with 
95% confidence. The duration of postoperative stay 
did not differ between groups, but to avoid dismiss- 
ing the possibility of a significant effect of perfusion 
temperature, we undertook a stepwise regression 
analysis. This identified age and ICU stay as signif- 
icant explanators of the variability in hospital stay. 
Despite allowance for these and other confounding 
variables, CPB temperature mained a nonsignifi- 
cant explanator. This observation lends support o 
the observed similarities in morbidity and mortality 
data among the three groups; any important differ- 
ences in these end points would have been expected 
to have influenced postoperative stay. 
Some important differences in the management of 
patients undergoing normothermic systemic perfu- 
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Fig. 1. Distribution of degree of inotropic support re- 
quired after the operation. ?Ninety percent of patients 
received opamine at a dose between 3 and 5/xg/kg per 
minute. 
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Fig. 2. Number of patients requiring transfusion ofblood 
and blood products. *p < 0.05 versus 28 ° C; tp < 0.05 
versus 28 ° C and 32 ° C. 
sion need to be appreciated and deserve some 
discussion. In agreement with the findings of other 
workers, the systemic vascular esistance was lower 
during normothermic CPB, and significantly larger 
doses of vasoconstrictors were administered in the 
warm group to maintain adequate perfusion pres- 
sures, s-7 This may represent a limitation of normo- 
thermia: First, the maintenance of CPB perfusion 
pressure requires increased vigilance on the part of 
the perfusionists to avoid hypoperfusion of the 
major organs, particularly with respect o the warm, 
metabolically active brain; second, increased vaso- 
constrictor administration may be detrimental to 
blood flow along arterial conduits. DiNardo and 
associates s demonstrated a significant decrease in 
internal thoracic artery graft flow when phenyleph- 
rine (76 _+ 31 /xg/min) was used to elevate mean 
arterial pressures by 20 mm Hg. Using a canine 
model in which blood pressure, heart rate, and 
cardiac output remained constant, Jett and cowork- 
ers 9 significantly reduced internal thoracic artery 
flow after administration f phenylephrine ata dose 
of 2 txg/min. 
The observation that patients in the normother- 
mic group required minimal doses of inotropic 
agents in the early postoperative period was not 
reflected by differences in intraaortic balloon pump 
support and perioperative myocardial infarction 
rates in the study. Although this is only a clinical 
observation, patients in the normothermic group 
were often observed to remain warm and well 
perfused peripherally, and the pattern of inotropic 
use in the intensive care may have reflected the 
continued vasodilation associated with warm CPB. 
The heart reverted to sinus rhythm after removal 
of the crossclamp more often after normothermic 
CPB than after hypothermic CPB, an observation 
that has been previously demonstrated by others 
using warm blood cardioplegia. 5 Whether this re- 
sults in a reduction in reperfusion injury is not 
known but would be a useful area for further study. 
Only five patients returned to the operating room 
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*p < 0.02 versus 28 ° C; tp < 0.05 versus 28 ° C; Sp < 0.002 
versus 28 ° C, p < 0.04 versus 32 ° C. 
because of continued bleeding after the operation, 
so that any statistical comparison between groups 
was not possible. Total chest tube drainage in the 
present study was not different between the groups, 
which contradicts the findings of others who have 
suggested a reduced bleeding tendency after normo- 
thermic perfusion. 1°42 However, the increased use 
of blood transfusion when the hematocrit value fell 
below 25% and the reduced need for fresh frozen 
plasma and platelet ransfusion in the normother- 
mic group did lend support to the concept of 
reduced postoperative coagulopathy state after 
warm systemic perfusion. 
Although normothermic systemic perfusion was 
at least as safe as conventional hypothermic CPB for 
routine coronary revascularization in this study, it 
nevertheless offered no major advantage with regard 
to clinical outcome. In addition, we have previously 
found no beneficial influence of normothermic sys- 
temic perfusion temperature on pulmonary gas ex- 
change 13 and renal function. 14 The reduced inci- 
dence of ventricular fibrillation on reperfusion and 
the lower requirements for transfusion of potentially 
harmful blood products, although favorable, need to 
be appreciated within the context of the growing 
evidence from randomized investigations that asso- 
ciates normothermia with an increased incidence of 
cerebral dysfunction. Martin and colleagues 15con- 
ducted a randomized trial of warm blood cardiople- 
gia and systemic normothermia (->35 °C) versus 
cold crystalloid cardioplegia nd hypothermic per- 
fusion (-<28°C) and demonstrated significantly 
higher stroke rates in the normothermic group 
(3.1% vs 1.0%, respectively). The authors subse- 
quently reported a multivariate analysis to address 
the criticisms of their initial findings that blood 
glucose was elevated in the normothermic group. 
This analysis did not identify systemic blood glucose 
as a predictor for stroke in the series. 1547 In another 
study, Craver and associates 17investigated 379 pa- 
tients undergoing coronary artery operations with 
hypothermic retrograde blood cardioplegia nd hy- 
pothermic perfusion (29 ° C to 33 ° C) and compared 
them with retrospective control subjects receiving 
retrograde warm blood cardioplegia nd normo- 
thermic perfusion. The incidence of postoperative 
neurologic events, however, was significantly higher 
in the normothermic group (4.7% vs 1.8%), substan- 
tiating concerns regarding the deleterious effects of 
normothermic perfusion on cerebral integrity. Mora 
and coworkers 18 have also found perioperative neu- 
rologic injury to be more prevalent after normother- 
mic (>35 °C) CPB. We recently completed a pro- 
spective randomized study in which 96 patients were 
randomized into one of three groups according to 
CPB temperature (28 ° C, 32 ° C, and 37 ° C) and cold 
antegrade crystalloid cardioplegia was used in all 
cases. Patients were subjected to detailed neurologic 
examination after the operation, and neuropsycho- 
logic evaluation was undertaken both before and 6 
weeks after the operation using the Wechsler Adult 
Intelligence Scale-revised. Although no focal neu- 
rologic deficits were recorded in the study, detailed 
multivariate analyses suggested that the incidence of 
neuropsychologic deficit was higher after normo- 
thermic perfusion (37 ° C) than after moderate hy- 
pothermic perfusion (32 ° C), with no added benefit 
conferred by lowering perfusion temperature to 
28 ° C. 19 Some evidence suggests that normothermia 
does not result in an increased risk of stroke, 3' 2o and 
the controversy remains to be resolved, but if nor- 
mothermic CPB proves to be detrimental to cere- 
bral function, there may be little incentive for its 
routine use during coronary artery operations. 
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Conclusions 
CPB temperature did not influence early clinical 
outcome after routine coronary artery bypass oper- 
ations. Normothermic systemic perfusion was asso- 
ciated with an increased requirement for vasocon- 
strictors and reduced requirements for electrical 
defibrillation and transfusion of blood products. 
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